AbCellera secures COVID-19 drug development funding

By The Science Advisory Board staff writers

May 4, 2020 -- AbCellera Biologics has secured $175.6 million Canadian ($124.7 million U.S.) from the Canadian government's Innovation, Science, and Economic Development Strategic Innovation Fund to advance its efforts to discover antibodies for use in antiviral COVID-19 drugs.

The company developed an antibody discovery platform to search blood samples of people who have recovered from COVID-19. In a collaboration with the U.S. National Institutes of Health, it has identified more than 500 anti-SARS-CoV-2 antibodies since February 25.

Under phase I of the Canadian collaboration, AbCellera will improve its antibody discovery platform for finding COVID-19 antibodies, while under phase II, it will build a new good manufacturing practice (GMP) facility in Vancouver to produce antibodies from patient samples for clinical trials.

AbCellera recently announced a partnership with Eli Lilly to develop a COVID-19 treatment, with clinical trials beginning in July, it said.

Researchers investigate how a potent mAb blocks SARS-CoV-2
Based on previous research that explored therapies against SARS-CoV, a new report has identified a fully human monoclonal antibody (mAb) that prevents...
Valo to develop pan-coronavirus vaccine
Valo Therapeutics announced that it is working on the development of a potential COVID-19 vaccine with applications across future pandemics.
WHO cautions against coronavirus 'immunity passports'
The World Health Organization (WHO) has published a report expressing caution about the value of antibody tests for the novel coronavirus and saying that...
Experts discuss promising strategies for tackling SARS-CoV-2
What's the best strategy for developing treatments for the SARS-CoV-2 virus? The most promising approaches for a rapid response are antivirals and gene...
COVID-19 vaccine candidates show progress amid challenges
As the COVID-19 outbreak advances worldwide, companies are stepping up to the challenge to develop a potential vaccine. There are over 75 confirmed COVID-19...

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter